Cargando…
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations
Viral vectors have been widely investigated as tools for cancer immunotherapy. Although many preclinical studies demonstrate significant virus-mediated tumour inhibition in synergy with immune checkpoint molecules and other drugs, the clinical success of viral vector applications in cancer therapy c...
Autores principales: | Spunde, Karina, Korotkaja, Ksenija, Zajakina, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495732/ https://www.ncbi.nlm.nih.gov/pubmed/36140243 http://dx.doi.org/10.3390/biomedicines10092142 |
Ejemplares similares
-
Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell Spheroids
por: Korotkaja, Ksenija, et al.
Publicado: (2023) -
Recombinant Virus Quantification Using Single-Cell Droplet Digital PCR: A Method for Infectious Titer Quantification
por: Korotkaja, Ksenija, et al.
Publicado: (2023) -
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model
por: Trofimova, Olga, et al.
Publicado: (2021) -
Characterization of Novel Biopolymer Blend Mycocel from Plant Cellulose and Fungal Fibers
por: Irbe, Ilze, et al.
Publicado: (2021) -
(UV inactivation of Semliki Forest virus and)(E. coli)(bacteria by alternative light sources)
por: Skudra, Atis, et al.
Publicado: (2022)